• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Dr. Robert J. Suhadolnik, HIV and cfs researcher died

justy

Donate Advocate Demonstrate
Messages
5,524
Location
U.K
I don't know much about his work, but it looks like he was a dedicated man, from the link posted above. The discoveries he made in CFS were in 1997 - 22 years ago, and still people are arguing about it being a 'real' illness.

Thanks for the work you did Robert, and may you rest in peace x
 

shannah

Senior Member
Messages
1,429
From the article

"In patients with chronic fatigue syndrome, the researchers discovered a defective enzyme in their white blood cells. At one time, the ailment, which causes disabling exhaustion and flulike symptoms, was thought to be linked to depression and was considered a mental illness - a view superseded by the research of Dr. Suhadolnik and others.

"Something new is going on in chronic fatigue syndrome," Dr. Suhadolnik testified before Congress in May 1997. "RNASE L [an enzyme] was overactive, unlike anything we had ever seen before.

"We have had another surprise - we have seen a new form of RNase L, a smaller form of RNase L - in people with chronic fatigue syndrome.

"It is tempting to speculate that the presence and activity of the new form of RNase L correlates with the severity of clinical symptoms in people with [the disease]," he told the representatives.

Dr. Suhadolnik eventually patented a biological marker for chronic fatigue syndrome that was licensed through Temple to RED Laboratories of Belgium."

Read more at http://www.philly.com/philly/news/2...0__Temple_biochemist.html#tHHzZtTr0FsAlHhL.99
 

valentinelynx

Senior Member
Messages
1,310
Location
Tucson
I remember hearing him speak at, I think it was the AACFS conference in San Francisco in 1996. I remember thinking how promising the research field was looking. Shocking to think that was almost 20 years now.

Wish I could find the actual program for the conference. I did find this tentative schedule from an announcement for it. Amazing to review the names and topics and see how little has changed. I don't think Suhadolnik is on the tentative schedule - his research was just being released at this time, so his presentation was big, breaking news.

From "Chronic Fatigue Syndrome Electronic Newsletter
No. 57 April 30, 1996 Washington DC":


>>>1. October CFS medical conference in San Francisco

The American Association for Chronic Fatigue Syndrome (AACFS) will
hold a major medical conference on CFS research and clinical issues
during October 13-17, 1996 in San Francisco. The articles below
contain a tentative schedule of conference events, the conference
registration form, and AACFS membership information.



>>>2. Tentative conference schedule

The following is a tentative schedule of the five days of conference
events. It is subject to many changes, and is shown here only to
give a sense of the intended breadth of the conference. A revised
schedule will appear in a future edition of CFS-NEWS, after the
presenters have been chosen.

---------------
Sunday, Oct. 13
---------------

Special Session: Satellite Symposium in
Conjunction with American College of Nutrition
Panel Discussion: Controversies in the
Nutritional Management of CFS

------------------------------------------------------

AACFS Scientific Program Opens

Opening Remarks: Paul Levine, MD; Mark Demitrack, MD
Keynote Address: TBA

Scientific Session I - Epidemiology
Co-chairs: Paul Levine, MD; Andrew Lloyd, MD
Plenary Address -- New insights into the Epidemiology
of CFS: Andrew Lloyd, MD
[Presentations of peer-reviewed research]

Scientific Poster Sessions - Moderated Exhibit of
Selected Scientific Studies
Co-Chairs: Dharam V. Ablashi, DVM; Murray Gardner, MD

Discussion Breakout Groups: TBA

---------------
Monday, Oct. 14
---------------

Scientific Session II - Interdisciplinary Studies
Co-Chairs: Mark Demitrack, MD; Iris Bell, MD
Plenary Address - Multiple Chemical Sensitivity and
Clinical Ecology: Iris Bell, MD
[Presentations of peer-reviewed research]

Luncheon Workshops
1: Immunology
Co-Chairs: Nancy Klimas,MD; Jay A. Levy, MD
2: The Quest for Homogeneity in the Case Definition
Chair: Benjamin Natelson, MD

Scientific Session III - Microbiology and Immunology
Co-Chairs: Jay Levy, MD; Theresa Whiteside, MD
Plenary address: TBA

[Presentations of peer-reviewed research]

Scientific Poster Sessions
Co-Chairs: Dharam Ablashi, DVM; Murray Gardner, MD

Discussion Breakout Groups: TBA

Dinner Workshops
3: International Clinical and Research Perspectives
Co-Chairs: Paul H. Levine, MD;
Kenny de Meirlier, MD
4: NIH Research Grant Opportunities: Application and
Review Process
Chair: Marcel Pons, MD

---------------
Tuesday, Oct.15
---------------

Scientific Session IV - Physiology
Co-Chairs: James Jones, MD; Peter Behan, MD
Plenary Address: Muscle studies and
organophosphates
Peter Behan, MD
[Presentations of peer-reviewed research]

Luncheon Workshops
5: Environmental Toxicology
Chair: Iris Bell, MD
6: Neuropsychological Functioning in CFS
Chair: John DeLuca , MD
Karen Schmaling, PhD
Paul Marshall, MD
Jordan Grafman, MD

Scientific Session V - Clinical Studies
Co-Chairs: Dedra Buchwald, MD; Michael Sharpe, MD
Plenary Address - Cognitive Behavioral Therapy:
Implications for CFS:
Michael Sharpe, MD
[Presentations of peer-reviewed research]

Banquet
Speaker: David Spiegel, MD
Interface of Mind and Body: Lessons learned
from breast cancer patients regarding
long-term outcomes and treatment strategies

Sometime during the Research Conference there will be a talk by
Janice Kiecolt-Glaser, MD on "Psychological Influence of
Immunoendocrine Interactions", and by Ronald Glaser, MD on
"Stress-associated Immune modulation: Implications for Health".

------------------------------------------------------

AACFS Clinical Conference Opens

------------------
Wednesday, Oct. 16
------------------

Clinical Session I

Welcoming Remarks: David S. Bell, MD

Review of Research Conference: Anthony Komaroff, MD

Overview of the Clinical Approach to CFS:
Current Treatment Strategies in the US and Abroad
Chair: Dedra Buchwald, MD
Panel: Jonathan Rest, MD; Kenny DeMierlier, MD

Q & A Session

Clinical Session II

Role of Psychotherapy and Psychotropics:
Chair: Mark Demitrack, MD
Panel: Michael Sharpe, MD; others TBA

Gulf War Illness and CFS: speaker TBA

Q & A Session

Clinical Keynote Address: TBA

Luncheon Workshops
1: Doctor-to-doctor (MD's only)
Co-chairs: Nancy Klimas, MD; Mark Loveless, MD
2: The relationship between CFS and "chronic fatigue"
Chair: Jonathan Rest, MD
3: The CFS Experience
Co-chairs: Patricia Fennell, CSW;
Fred Friedberg, PhD
Clinical Session III

Rehabilitation Strategies - Panel Discussion
Co-Chairs: Sue Ann Sisto, PhD;
Gloria Furst, OTR/L, MPH
Panel: TBA

The Determination of Disability - Panel Discussion
Co-Chairs: Daniel Peterson, MD; Peter Manu, MD
Panel: Barry Make, MD; Thomas Lane, MD;
Jordan Grafman, MD
Discussants: Tom Gloss, MD; Marcia Scott, MD

Q & A Sessions (Separate Areas for the speakers in
the 2 sessions above. Extended timeframe for
individual questions)

AACFS Business Meeting

Break

Dinner Workshops
4: Long-Term Prognosis of CFS
Chair: Dedra Buchwald, MD
5: Complementary Medicine and Nutritional
Controversies
Chair: Paul H. Levine, MD
Panel: TBA

-----------------
Thursday, Oct. 17
-----------------

Clinical Session IV

Silicone Implants and CFS: An Ongoing Controversy
Henry Claman, MD

Q & A Session

Clinical Session V

Autonomic Nervous System and Fibromyalgia,
Neuroendocrine Abnormalities and Neurally Mediated
Hypotension in CFS
Panel: Daniel Clauw, MD; Peter Rowe, MD;
Stanley Schwartz, MD

Q & A Session

CFS in Adolescents
Co-chairs: David Bell, MD; James Jones, MD
Panel: TBA

Q & A Session

Luncheon Workshops
7: Cognitive Dysfunction - When to Evaluate?
Panel: Daniel Peterson, MD; Jordan Grafman, MD
8: Individual Case Review (MD's only)
Panel of clinical experts

Clinical Session VI

Long-Term Patient Management
Panel: Nancy Klimas, MD; Patricia Fennell, PhD;
Michael Sharpe, MD; James Jones, MD

Clinical Session VII

Ask the Experts - Panel Discussion
Moderator: Anthony L. Komaroff, MD
Panel: TBA

Concluding Remarks: David S. Bell, MD